Our present study showed that EMAP II induced the most significant decrease in GECs viability was 0.05 nM EMAP II treatment for 3 h, but our previous study showed that the viability of GBM and GSCs reduced the most significantly was at 0.05 nM for 0.5 h. Here, AIMP1 is linked to glioblastoma.